Dr Mandeep Malhotra-Surgical & Molecular Oncology
A Surgical Oncologist with sub-specialization in Head Neck & Breast Oncology and more than 20 years of patient treatment experience, Dr. Mandeep is currently working with CK Birla Hospital,Punjabi Bagh,New Delhi as Director-Surgical Oncology and has previously also worked with Fortis Hospital, Vasant Kunj, as Sr. Consultant & Head of Department – Head Neck & Breast Oncoplasty.
Dr Mandeep Malhotra-Surgical & Molecular Oncology
3 months ago | [YT] | 0
View 0 replies
Dr Mandeep Malhotra-Surgical & Molecular Oncology
What is fuelling India’s most common cancers in men and women? Oncologists reveal
According to a new study by the Indian Council of Medical Research (ICMR), published in The Journal of the American Medical Association (JAMA), India recorded an estimated 1.56 million new cancer cases and 874,404 deaths in 2024 alone.
The report, titled Cancer Incidence and Mortality Across 43 Cancer Registries in India, also projected that if current trends continue, the country could see as many as 2.46 million cancer cases annually by 2045.
“Breast cancer is rising rapidly in India. While a small percentage of cases are hereditary, the majority are lifestyle-related. Modern factors such as late pregnancies, obesity, alcohol use, and high stress all contribute to the rise,” explains Dr. Mandeep Singh Malhotra, Director of Surgical Oncology at the CK Birla Hospital, Delhi.
Read Complete article here : www.financialexpress.com/life/health/what-is-fuell…
#CancerAwareness #IndiaCancerStats #BreastCancerAwareness #PreventCancer #OncologyInsights #LifestyleAndCancer #CancerPrevention #CancerCareIndia #ICMRStudy #CancerResearch #FightCancerTogether #HealthAwareness #DrMandeepSinghMalhotra
4 months ago | [YT] | 0
View 0 replies
Dr Mandeep Malhotra-Surgical & Molecular Oncology
आयुष्मान खुराना की वाइफ को फिर हुआ कैंसर, डॉ. ने बताया ठीक होने के बाद ब्रेस्ट कैंसर के लौटने का कारण
ब्रेस्ट कैंसर के दोबारा होने का कारण
डॉक्टर बताते हैं कि ब्रेस्ट कैंसर के कई प्रकार होते हैं, जैसे कि हार्मोन रिसेप्टर-पॉजिटिव, HER2-पॉजिटिव और ट्रिपल-नेगेटिव. हार्मोन रिसेप्टर-पॉजिटिव कैंसर कम आक्रामक होते हैं, लेकिन ये कई वर्षों बाद भी वापस आ सकते हैं. वहीं, HER2-पॉजिटिव और ट्रिपल-नेगेटिव कैंसर अधिक आक्रामक होते हैं और जल्दी वापस आ सकते हैं. इसके साथ ही यदि पहली बार ब्रेस्ट कैंसर एडवांस लेवल पर पहुंच गया है, तो इसके दोबारा होने की संभावना ज्यादा होती है.
9 months ago | [YT] | 0
View 0 replies
Dr Mandeep Malhotra-Surgical & Molecular Oncology
The Role of Herbs in Cancer Treatment | Dr Mandeep Singh Malhotra
1 year ago | [YT] | 0
View 0 replies